Advertisement

Topics

Catalyst Biomedica Limited Company Profile

00:00 EDT 26th March 2019 | BioPortfolio

Catalyst BioMedica is a company that enables and supports the translation of fundamental biomedical research into innovative products and technologies that will meet global healthcare needs. Catalyst is a business development subsidiary established by the Wellcome Trust to work with scientists and their host institutions. The Wellcome Trust is the world's largest medical research charity, with an annual expenditure of more than £600 million (US$900 million).

At Catalyst we aim to provide a complementary resource to University technology transfer professionals, to protect intellectual property, to administer the funding of selected applied research and to promote the delivery of benefits for healthcare. At the same time we want to ensure that the benefits of new technologies will be shared equitably among those who generate them and those who fund and facilitate their transfer to the commercial sector.

Location

183 Euston Road
London
NW1 2BE
United Kingdom

Contact

Phone: +44 (0) 207 611 8802
Fax: +44 (0) 207 611 8857
Email: catalyst@wellcome.ac.uk


News Articles [402 Associated News Articles listed on BioPortfolio]

Oxford BioMedica Notes the Longer-Term Analyses from Pivotal Kymriah Trials, Which Showed Durable Responses Are Maintained in Patients with Advanced Blood Cancers

Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell therapy group, today notes an announcement by Novartis on the longer-term analyses of both the ELIANA an...

Oxford BioMedica: Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy

Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrate...

Oxford BioMedica unveils digital initiative to streamline manufacturing

UK gene and cell therapy group Oxford BioMedica has announced a new digital framework initiative to streamline the production of next-generation medicines.

Catalyst OrthoScience gets FDA approval for Press Fit humeral implant

The new Press Fit humeral component is a continued evolution of the Catalyst CSR total shoulder system, which is a disruptive technology launched in 2016. Catalyst is planning The post Catalyst Ortho...

Oxford Biomedica Reports Pretax Profit In 2018; Revenue Up 78%

LONDON (dpa-AFX) - Oxford Biomedica plc (OXB.L) reported profit before tax of 5.0 million pounds for the year ended 31 December 2018 compared to a loss of 11.8 million pounds, previous year. Profi...

Idexx Introduces new canine progesterone test for Catalyst Dx & Catalyst One chemistry analyzers

Idexx Laboratories, Inc., a global leader in veterinary diagnostics and software, announced that it is introducing a new canine progesterone test for Catalyst Dx and Catalyst One chemistry analyzers. ...

Catalyst Biosciences to provide results in one of its hematology trials in 3Q 2019

Catalyst Biosciences (NASDAQ:CBIO) Dr. Nassim Usman spoke with Proactive Investors at the BIO CEO & Investor Conference in New York. Catalyst is a clinical-stage biopharmaceutical company deve...

Oxford Biomedica, Microsoft Pact Aims At Better, Cheaper Lentiviral Vectors

Oxford Biomedica and Microsoft have joined forces to improve the yield and quality of next-generation gene therapy vectors using the...   

Drugs and Medications [34 Associated Drugs and Medications listed on BioPortfolio]

Adenosine [wockhardt limited]

Adenosine Injection, USP FOR RAPID BOLUS INTRAVENOUS USE

Felodipine [wockhardt limited]

Felodipine Extended-Release Tablets, USP Rx only

Ranitidine [wockhardt limited]

Ranitidine Syrup (Ranitidine Oral Solution, USP)

Risperidone [wockhardt limited]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Amlodipine besylate [wockhardt limited]

These highlights do not include all the information needed to use amlodipine besylate tablets safely and effectively. See full prescribing information for amlodipine besylate tablets. Amlodipine Besyl...

PubMed Articles [509 Associated PubMed Articles listed on BioPortfolio]

Co-pyrolysis of biomass and soapstock in a downdraft reactor using a novel ZSM-5/SiC composite catalyst.

A ZSM-5/SiC composite catalyst was synthesized and characterized by Brunauer-Emmett-Teller analysis, X-ray diffraction, and scanning electron microscopy in this study. The composite catalyst had the c...

Heavy metal poisoned and regeneration of selective catalytic reduction catalysts.

Being poison to heterogeneous catalysts, Pb and As are important metals in the study of industrial NO emission reductions. A series of VO-WO/TiO-SiO catalysts poisoned by Pb and As were prepared throu...

Magnetic hybrid of cyclodextrin nanosponge and polyhedral oligomeric silsesquioxane: Efficient catalytic support for immobilization of Pd nanoparticles.

For the first time a novel magnetic catalyst was prepared through hybridization of functionalized cyclodextrin nanosponges and octakis(3-chloropropyl)octasilsesquioxane followed by incorporation of Pd...

Microwave field: High temperature dielectric properties and heating characteristics of waste hydrodesulfurization catalysts.

The exploration of the dielectric properties of waste hydrodesulfurization catalysts has important guiding significance for the development of microwave heat treatment of waste hydrodesulfurization ca...

Selective CO Evolution from Photoreduction of CO2 on a Metal-Carbide-Based Composite Catalyst.

A selective CO evolution from photoreduction of CO2 in wa-ter was achieved on a noble-metal-free, carbide-based compo-site catalyst, as demonstrated by a CO selectivity of 98.3% among all carbon-conta...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

Newborn Heart Rate as a Catalyst for Improved Survival

Heart rate (HR) is not routinely assessed during newborn resuscitations in low- and lower-middle income countries (LMICs). Many non-breathing newborns classified as fresh stillbirths have ...

Basic Knowledge of CPR Among Close Relatives of Heart Patients-check Status Quo and Attemp to Establish a Potential Plan to Implement This Knowledge

Cardiac arrest is a public health problem and is the leading cause of death in many parts of the world. Cardiac arrest can occur inside the hospital and outside it. In the United States a...

Companies [206 Associated Companies listed on BioPortfolio]

Catalyst Biomedica Limited

Catalyst BioMedica is a company that enables and supports the translation of fundamental biomedical research into innovative products and technologies that will meet global healthcare needs. Catalyst ...

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

Boston Biomedica Incorporated

Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral He...

Oxford BioMedica plc

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

More Information about "Catalyst Biomedica Limited" on BioPortfolio

We have published hundreds of Catalyst Biomedica Limited news stories on BioPortfolio along with dozens of Catalyst Biomedica Limited Clinical Trials and PubMed Articles about Catalyst Biomedica Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Biomedica Limited Companies in our database. You can also find out about relevant Catalyst Biomedica Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record